BMS
MCID: BRN009
MIFTS: 54

Burning Mouth Syndrome (BMS) malady

Categories: Rare diseases, Neuronal diseases, Oral diseases

Aliases & Classifications for Burning Mouth Syndrome

About this section

Aliases & Descriptions for Burning Mouth Syndrome:

Name: Burning Mouth Syndrome 11 48 54 39 13 68
Stomatodynia 48 54 68
Stomatopyrosis 11 54
Orodynia 11 54
 
Bms 48 54
Burning Mouth Disorder 48
Oral Dysesthesia 54

Classifications:



External Ids:

Disease Ontology11 DOID:4331
MeSH39 D002054
NCIt45 C62545
Orphanet54 ORPHA353253
ICD10 via Orphanet31 K14.6

Summaries for Burning Mouth Syndrome

About this section
NIH Rare Diseases:48 Burning mouth syndrome is characterized by long-lasting burning sensations of the mouth. the pain may affect the tongue, gums, lips, palate, throat, or the entire mouth. burning mouth syndrome may be primary or secondary. experts believe that the primary form may be caused by damage to the nerves that control pain and taste. the secondary form is caused by an underlying medical condition. in many cases, the underlying cause in unknown. treatment depends on the symptoms present and aims to control them. last updated: 3/28/2016

MalaCards based summary: Burning Mouth Syndrome, also known as stomatodynia, is related to neuropathy and stomatitis, and has symptoms including oral manifestations and burning tongue. An important gene associated with Burning Mouth Syndrome is TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1), and among its related pathways are Trk receptor signaling mediated by PI3K and PLC-gamma and Overview of nanoparticle effects. Affiliated tissues include tongue, testes and skin, and related mouse phenotypes are behavior/neurological and neoplasm.

Wikipedia:71 Burning mouth syndrome (BMS) is a burning sensation in the mouth with no underlying dental or medical... more...

Related Diseases for Burning Mouth Syndrome

About this section

Diseases in the Burning Mouth Syndrome family:

Burning Mouth Syndrome Type 3

Diseases related to Burning Mouth Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 209)
idRelated DiseaseScoreTop Affiliating Genes
1neuropathy30.0IL1B, IL6, TNF
2stomatitis29.8IL2, IL6
3burning mouth syndrome type 312.1
4glossodynia11.3
5glossitis11.1
6burns11.0
7acute allergic sanguinous otitis media10.3IL2, IL6
8labyrinthine bilateral reactive loss10.2IL2, IL6
9oculomotor nerve paralysis10.2IL1B, IL6
10common peroneal nerve lesion10.2IL1B, IL6
11childhood electroclinical syndrome10.2IL1B, IL6
12vps11-related autosomal recessive hypomyelinating leukodystrophy10.2IL6, TNF
13glucosephosphate dehydrogenase deficiency10.2IL1B, IL6
14steatitis10.2IL2, TNF
15malignant renovascular hypertension10.2NGF, TAC1
16dyslexia 510.2IL6, TNF
17aortic atherosclerosis10.2IL6, TNF
18degenerative disc disease10.2IL6, TNF
19pseudoinflammatory fundus dystrophy10.2NGF, TAC1
20unilateral multicystic dysplastic kidney10.2IL6, TNF
21swine influenza10.2IL6, TNF
22autosomal dominant deafness-onychodystrophy syndrome10.2IL2, TNF
23drug dependence10.1IL6, TNF
24transient tic disorder10.1IL6, TNF
25severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive10.1IL2, TNF
26papilledema10.1IL6, TNF
27angiomatosis, diffuse corticomeningeal, of divry and van bogaert10.1IL6, TNF
28hemangioma of orbit10.1IL2, TNF
29aortic coarctation10.1IL6, TNF
30bullous retinoschisis10.1IL1B, IL6
31preaxial polydactyly of fingers10.1IL6, TNF
32carbuncle10.1IL1B, IL6
33inhalation anthrax10.1TAC1, TRPV1
34esophagus lymphoma10.1IL6, TNF
35intussusception10.1IL1B, TNF
36vogt-koyanagi-harada disease10.1IL6, TNF
37plantar wart10.1IL2, TNF
38larynx leiomyoma10.1IL1B, IL6
39retinal artery occlusion10.1IL1B, NGF
40parametritis10.1IL2, TNF
41tau syndrome10.1IL1B, TNF
42laryngotracheoesophageal cleft type 210.1IL1B, IL2, IL6
43stocco dos santos syndrome10.1IL1B, TNF
44lichen planus10.1
45hypotrichosis-lymphedema-telangiectasia-renal defect syndrome10.1IL1B, TNF
46twin-to-twin transfusion syndrome10.1IL1B, TNF
47stickler syndrome, type v10.1IL1B, IL2, IL6
48gastric leiomyoma10.1IL1B, IL6
49warthin tumor10.1IL1B, TNF
50cataract10.1IL1B, TNF

Graphical network of the top 20 diseases related to Burning Mouth Syndrome:



Diseases related to burning mouth syndrome

Symptoms & Phenotypes for Burning Mouth Syndrome

About this section

UMLS symptoms related to Burning Mouth Syndrome:


oral manifestations, burning tongue

MGI Mouse Phenotypes related to Burning Mouth Syndrome according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053868.0IL2, IL6, NGF, SCN9A, TAC1, TNF
2MP:00020067.9IL1B, IL2, IL6, TNF, TRPV1
3MP:00107717.6IL1B, IL6, NGF, SCN9A, TAC1, TNF
4MP:00053857.5IL1B, IL2, IL6, NGF, TAC1, TNF

Drugs & Therapeutics for Burning Mouth Syndrome

About this section

Drugs for Burning Mouth Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 159)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Clonazepamapproved, illicitPhase 4, Early Phase 1321622-61-32802
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
CID2802
CLONAZEPAM
Chlonazepam
Cloazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
DB01068
DEA No. 2737
 
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
LS-34156
LS-34260
Landsen
Lktorivil
Lonazep
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
RO4023
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4-8180
Ro 4023
Ro 5-4023
Ro 5-4023/B-7
Ro 54023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
clonazepam
2
Cyclosporineapproved, investigational, vet_approvedPhase 4, Phase 392279217-60-0, 59865-13-35284373, 6435893
Synonyms:
1c5f
1cyn
30024_FLUKA
30024_SIGMA
59865-13-3
79217-60-0
AC1L1EQW
AC1NQXJE
AC1NR4C4
AC1NUQK3
AC1NUZNC
AC1O5KOG
AC1Q2UDG
Ambap59865-13-3
Ambotz59865-13-3
Antibiotic S 7481F1
BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA
BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA
BPBio1_000496
BRD-A64290322-001-01-6
BRD-A69815203-001-04-3
BRD-K13533483-001-03-0
BSPBio_000450
BSPBio_001596
BSPBio_003186
C 3662
C05086
C1832_SIGMA
C3662_SIGMA
C62H111N11O12
CB-01-09 MMX
CHEBI:106343
CHEBI:328305
CHEBI:4031
CHEMBL160
CHEMBL386389
CHEMBL532318
CID2909
CID5280754
CID5284373
CID5458585
CID5497195
CID6435893
CSA
CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A))
CYCLOSPORIN A, USP
Ciclosporin
Ciclosporin (JP15)
Ciclosporina
Ciclosporine
Ciclosporinum
Cipol N
Cipol-N
Consupren
Consupren S
CsA
CsA & IFN.alpha.
CyA
Cyclokat
Cyclosporin
Cyclosporin A
Cyclosporin A & IFN.alpha.
Cyclosporin A Implant
Cyclosporin A, Tolypocladium inflatum
Cyclosporine (USP)
Cyclosporine A
Cyclosporine [USAN]
D00184
DE-076
DivK1c_000871
EU-0100242
Equoral
GNF-Pf-2808
Gengraf
Gengraf (TN)
HMS1569G12
HMS1791P18
HMS1921L20
HMS1989P18
HMS2089A09
HMS2092F06
HMS502L13
Helv Chim Acta 60: 1568 (1977)
 
I06-0379
I06-0966
IDI1_000871
KBio1_000871
KBio2_000780
KBio2_003348
KBio2_005916
KBio3_002686
KBioGR_001898
KBioSS_000780
LMPK14000003
LS-257
LS-58836
Lopac0_000242
MLS000028376
MLS001333756
MLS002153454
MLS002207033
Mitogard
Modusik-A
MolPort-000-760-988
MolPort-005-934-008
MolPort-006-705-994
NCGC00093704-01
NCGC00093704-02
NCGC00093704-03
NCGC00093704-04
NCGC00093704-05
NCGC00093704-06
NCGC00093704-07
NCGC00093704-08
NCGC00164258-01
NCGC00164258-02
NINDS_000871
NSC290193
Neoplanta
Neoral
Neoral (TN)
NeuroSTAT
Nova-22007
OL 27-400
OL-27400
OLO-400
Papilock
Prestwick2_000435
Prestwick3_000435
Prestwick_731
Pulminiq
Ramihyphin A
Restasis
Restasis (TN)
S-Neoral
S1514_Selleck
SDZ-OXL 400
SMR000058578
SPBio_001467
SPECTRUM1502202
ST-603
Sandimmun
Sandimmun Neoral
Sandimmune
Sandimmune (TN)
Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine
Sang-2000
Sang-35
SangCyA
Sangcya
Sigmasporin
Sigmasporin Microoral
Spectrum2_001484
Spectrum3_001593
Spectrum4_001279
Spectrum5_001628
Spectrum_000300
TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)
Vekacia
Zyclorin
cyclophorine
cyclosporin A
cyclosporine
from Tolypocladium inflatum (Trichoderma polysporin)
nchembio.184-comp6
nchembio.301-comp5
nchembio.342-comp1
3
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
4
EphedrineapprovedPhase 4628299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
5
PseudoephedrineapprovedPhase 462890-82-47028
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
pseudoéphédrine
trans-Ephedrine
ψ-ephedrine
6
TiclopidineapprovedPhase 447155142-85-35472
Synonyms:
5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
55142-85-3
AC-15204
AC1L1KFB
BIDD:PXR0169
BPBio1_000191
BRD-K00603606-003-03-4
BRN 1216802
BSPBio_000173
C07140
C14H14ClNS
CAS-53885-35-1
CHEBI:9588
CHEMBL833
CID5472
D08594
DB00208
EINECS 259-498-5
HMS2089I18
L001108
LS-152434
MLS001201825
MolPort-002-507-849
 
NCGC00016872-01
NCGC00016872-02
NCGC00024361-04
PCR 5332
Prestwick0_000047
Prestwick1_000047
Prestwick2_000047
Prestwick3_000047
SMR000641861
SPBio_002094
STK589340
STOCK5S-54105
Ticlid
Ticlopidin-Puren
Ticlopidin-Puren (TN)
Ticlopidina
Ticlopidina [INN-Spanish]
Ticlopidine (INN)
Ticlopidine HCL
Ticlopidine Hydrochloride
Ticlopidine [INN:BAN]
Ticlopidinum
Ticlopidinum [INN-Latin]
UNII-OM90ZUW7M1
UNM-0000345023
ZINC19594599
ticlopidine
7
TicagrelorapprovedPhase 4316274693-27-59871419
Synonyms:
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
AZD 6140
 
AZD-6140
AZD6140
Brilinta
8
Lidocaineapproved, vet_approvedPhase 41317137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
9
Epinephrineapproved, vet_approvedPhase 498551-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
10
Vitamin Aapproved, nutraceutical, vet_approvedPhase 449211103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
11
Vitamin Eapproved, nutraceutical, vet_approvedPhase 4, Phase 141459-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
12
Cholecalciferolapproved, nutraceuticalPhase 4, Phase 287567-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
Colecalciferol
 
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D-3
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
cholecalciferol
colecalciferolum
vitamin d-3
13
Clopidogrelapproved, nutraceuticalPhase 4778120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
 
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
14Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Early Phase 118340
15Autonomic AgentsPhase 4, Phase 310150
16Anti-Infective AgentsPhase 4, Phase 3, Phase 222062
17Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 223689
18VitaminsPhase 4, Phase 2, Phase 15282
19Protective AgentsPhase 4, Phase 17443
20AntioxidantsPhase 4, Phase 13050
21MicronutrientsPhase 4, Phase 2, Phase 16001
22Bone Density Conservation AgentsPhase 4, Phase 23376
23TocopherolsPhase 4, Phase 1414
24Retinol palmitatePhase 4492
25Trace ElementsPhase 4, Phase 2, Phase 16001
26vitamin dPhase 4, Phase 21724
27TocotrienolsPhase 4, Phase 1410
28TetrahydrozolinePhase 4621
29Vasoconstrictor AgentsPhase 42122
30Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 23917
31AnticonvulsantsPhase 4, Early Phase 12695
32GABA ModulatorsPhase 4, Early Phase 1904
33GABA AgentsPhase 4, Early Phase 11684
34Ophthalmic SolutionsPhase 41140
35Respiratory System AgentsPhase 44997
36Antirheumatic AgentsPhase 4, Phase 310956
37Immunosuppressive AgentsPhase 4, Phase 3, Phase 213086
38Dermatologic AgentsPhase 4, Phase 35806
39Nasal DecongestantsPhase 4598
40Pharmaceutical SolutionsPhase 4, Phase 3, Phase 28192
41Antifungal AgentsPhase 4, Phase 3, Phase 23696
42Calcineurin InhibitorsPhase 4, Phase 31622
43AnestheticsPhase 4, Phase 29596
44Purinergic P2 Receptor AntagonistsPhase 4795
45Fibrinolytic AgentsPhase 42388
46Platelet Aggregation InhibitorsPhase 42516
47Purinergic P2Y Receptor AntagonistsPhase 4793
48RacepinephrinePhase 4985
49Anti-Infective Agents, LocalPhase 41880
50Epinephryl boratePhase 4985

Interventional clinical trials:

(show all 43)
idNameStatusNCT IDPhase
1Oral Nutrition Impact on Tear FilmUnknown statusNCT01561040Phase 4
2A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA StudyCompletedNCT02049112Phase 4
3Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry EyeCompletedNCT01488396Phase 4
4G-CSF in the Treatment of Toxic Epidermal NecrolysisRecruitingNCT02739295Phase 4
5Tailored Antiplatelet Therapy Following PCIRecruitingNCT01742117Phase 4
6TRPV Expression in Subjects With Sensitive SkinEnrolling by invitationNCT01871883Phase 4
7Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth SyndromeNot yet recruitingNCT02690844Phase 4
8Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of DeliriumUnknown statusNCT01811459Phase 3
9Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain DisordersCompletedNCT00374673Phase 3
10Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal DischargeCompletedNCT02111629Phase 3
11Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant PainCompletedNCT00312195Phase 3
12Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisNot yet recruitingNCT02987257Phase 3
13Effect of Rosuvastatin on Endothelial FunctionTerminatedNCT00986999Phase 2, Phase 3
14Botulinum Toxin in Burning Mouth SyndromeCompletedNCT02964728Phase 2
15Thalidomide to Treat Oral Lesions in HIV-Infected PatientsCompletedNCT00001524Phase 2
16Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell TransplantCompletedNCT00321932Phase 2
17CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive CandidiasisRecruitingNCT02734862Phase 2
18Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet TransplantationAvailableNCT02149732Phase 1, Phase 2
19Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral PainTerminatedNCT01584947Phase 2
20Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D PathwayTerminatedNCT01499940Phase 2
21Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantTerminatedNCT00602446Phase 2
22Vitamin E Supplementation in Burn PatientsRecruitingNCT01413620Phase 1
23Oral Rehydration Therapy in Burn PatientsEnrolling by invitationNCT02124265Phase 1
24Effect of Gluten Free Diet in Patients With Burning Mouth SyndromeUnknown statusNCT01867151
25Burning Mouth Disorder (BMD) - A Neuropathic Pain DisorderUnknown statusNCT00504387
26Minocycline Augmentation in SchizophreniaUnknown statusNCT01561742
27The Role of Xerostomia in Burning Mouth Syndrome: Case - Control StudyCompletedNCT01754740
28A Study of the Association of Sleep Dysfunction and Burning Mouth SyndromeCompletedNCT00862576
29Efficacy of Melatonin in Burning Mouth Syndrome (BMS)CompletedNCT02580734
30Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)CompletedNCT02686359
31Acupuncture Versus Clonazepam in Burning Mouth SyndromeCompletedNCT02382029Early Phase 1
32Neurogenic Mechanisms in Burning Mouth SyndromeCompletedNCT00875537
33Study Evaluating the Laser Diode Effect Burning Mouth SyndromeCompletedNCT02757612
34Alpha Lipoic Acid for Burning MouthCompletedNCT00387543
35Pain and Sensory Changes Assessment in HIV+ PatientsCompletedNCT00422695
36Evaluation and Treatment of Oral Soft Tissue DiseasesCompletedNCT00001601
37Citrulline Challenge Study for Healthy Subjects in the United KingdomCompletedNCT02772861
38HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth SyndromeRecruitingNCT01931293
39Assessment of Peripheral GABA Receptors for Local Pain ReliefRecruitingNCT02928328
40Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis ImplantationActive, not recruitingNCT02945176
41Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial PainTerminatedNCT00716807
42Evaluation of Salivary Gland DysfunctionTerminatedNCT00001196
43Low Level Laser Therapy for the Treatment of Provoked VestibulodyniaTerminatedNCT01149031

Search NIH Clinical Center for Burning Mouth Syndrome


Cochrane evidence based reviews: burning mouth syndrome

Genetic Tests for Burning Mouth Syndrome

About this section

Anatomical Context for Burning Mouth Syndrome

About this section

MalaCards organs/tissues related to Burning Mouth Syndrome:

36
Tongue, Testes, Skin, Thyroid, Colon, Cortex, Heart

Publications for Burning Mouth Syndrome

About this section

Articles related to Burning Mouth Syndrome:

(show top 50)    (show all 446)
idTitleAuthorsYear
1
Analgesic effect of topical oral capsaicin gel in burning mouth syndrome. (28007005)
2017
2
Neuropathic Pain in Patients with Burning Mouth Syndrome Evaluated Using painDETECT. (28057813)
2017
3
Effects of low-level laser therapy on burning mouth syndrome. (27893167)
2017
4
RF-Burning Mouth Syndrome: New Treatments. (27702434)
2017
5
Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome. (27862315)
2016
6
Burning mouth syndrome: Clinical description, pathophysiological approach, and a new therapeutic option. (26778734)
2016
7
Taste function assessed by electrogustometry in burning mouth syndrome: a case control study. (28029722)
2016
8
Burning mouth syndrome associated with varicella zoster virus. (27382016)
2016
9
The relationship between the clinical features of idiopathic burning mouth syndrome and self-perceived quality of life. (28025430)
2016
10
Opiorphin in burning mouth syndrome patients: a case-control study. (28013436)
2016
11
Low-dose aripiprazole for refractory burning mouth syndrome. (27279742)
2016
12
An overview of burning mouth syndrome. (26709657)
2016
13
Spatial and Temporal Brain Responses to Noxious Heat Thermal Stimuli in Burning Mouth Syndrome. (27302878)
2016
14
Peripheral nervous system involvement in primary burning mouth syndrome-results of a pilot study. (26847146)
2016
15
Burning Mouth Syndrome and "Burning Mouth Syndrome". (27209717)
2016
16
Efficacy of Low Level Laser Therapy in the Treatment of Burning Mouth Syndrome: A Systematic Review. (27919663)
2016
17
Polymorphisms of interleukin-1I^ and MUC7 genes in burning mouth syndrome. (27246755)
2016
18
Primary Burning Mouth Syndrome: A Questionnaire Study of Neuropathic and Psychological Components. (26691521)
2016
19
A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome. (26873501)
2016
20
Pain Part 8: Burning Mouth Syndrome. (27439272)
2016
21
Impact of reassurance on pain perception in patients with primary burning mouth syndrome. (27101802)
2016
22
Burning Mouth Syndrome. (27475513)
2016
23
Interventions for treating burning mouth syndrome. (27855478)
2016
24
Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases. (27558854)
2016
25
Low Intensity laser therapy in patients with burning mouth syndrome: a randomized, placebo-controlled study. (27737361)
2016
26
Characterization of Burning Mouth Syndrome in Patients with Parkinson's Disease. (27792799)
2016
27
Combined Acupuncture and Auriculotherapy in Burning Mouth Syndrome Treatment: A Preliminary Single-Arm Clinical Trial. (27585312)
2016
28
Burning Mouth Syndrome: A Review of the Etiopathologic Factors and Management. (27207008)
2016
29
Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study. (27834029)
2016
30
Grey matter changes of the pain matrix in patients with burning mouth syndrome. (26741696)
2016
31
Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis. (27121358)
2016
32
Burning Mouth Syndrome. (26962284)
2016
33
Comparative Analysis of Psychological, Hormonal, and Genetic Factors Between Burning Mouth Syndrome and Secondary Oral Burning. (26849950)
2016
34
An overview of burning mouth syndrome for the dermatologist. (26871710)
2016
35
Burning mouth syndrome. (26745781)
2016
36
The Detection of Small-Fiber Neuropathies in Burning Mouth Syndrome and Iatrogenic Lingual Nerve Injuries: Use of Quantitative Sensory Testing. (27128472)
2016
37
A systematic review of randomized trials for the treatment of burning mouth syndrome. (27302545)
2016
38
Co-occurrence of Pain Symptoms and Somatosensory Sensitivity in Burning Mouth Syndrome: A Systematic Review. (27657531)
2016
39
Management of burning mouth syndrome. (27134471)
2016
40
The effectiveness of acupuncture versus clonazepam in patients with burning mouth syndrome. (25987645)
2015
41
Evaluation of the efficacy of low-level laser in improving the symptoms of burning mouth syndrome. (26535101)
2015
42
The application of neuropathic pain questionnaires in burning mouth syndrome patients. (25905536)
2015
43
Characteristics of middle-aged and older patients with temporomandibular disorders and burning mouth syndrome. (26666859)
2015
44
Burning mouth syndrome: Current concepts. (26929531)
2015
45
Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial. (26034927)
2015
46
Phototherapy on the Treatment of Burning Mouth Syndrome: A Prospective Analysis of 20 Cases. (26138316)
2015
47
The nocebo effect might affect treatment expectations in patients with burning mouth syndrome. (25599458)
2015
48
Involvement of peripheral artemin signaling in tongue pain: possible mechanism in burning mouth syndrome. (26270588)
2015
49
Burning mouth syndrome: controversial place as a symptom of Oro-dental pathology. (26361508)
2015
50
Alice in Wonderland Syndrome, Burning Mouth Syndrome, Cold Stimulus Headache, and HaNDL: Narrative Review. (26422755)
2015

Variations for Burning Mouth Syndrome

About this section

Expression for genes affiliated with Burning Mouth Syndrome

About this section
Search GEO for disease gene expression data for Burning Mouth Syndrome.

Pathways for genes affiliated with Burning Mouth Syndrome

About this section

Pathways related to Burning Mouth Syndrome according to GeneCards Suite gene sharing:

(show top 50)    (show all 52)
idSuper pathwaysScoreTop Affiliating Genes
19.7NGF, TRPV1
29.5IL6, TNF
39.5IL6, TNF
49.5NGF, TNF
5
Show member pathways
9.4IL2, TNF
69.2IL1B, IL6
79.2IL1B, IL6
89.1IL1B, TNF
99.1IL1B, TNF
109.0IL2, IL6, TNF
119.0IL2, IL6, TNF
129.0IL2, IL6, TNF
138.7IL1B, IL6, TNF
148.7IL1B, IL6, TNF
158.7IL1B, IL6, TNF
168.7IL1B, IL6, TNF
17
Show member pathways
8.7IL1B, IL6, TNF
18
Show member pathways
8.7IL1B, IL6, TNF
198.7IL1B, IL6, TNF
208.7IL1B, IL6, TNF
21
Show member pathways
8.7IL1B, IL6, TNF
228.7IL1B, IL6, TNF
238.7IL1B, IL6, TNF
248.7IL1B, IL6, TNF
258.7IL1B, IL6, TNF
268.7IL1B, IL6, TNF
278.7IL1B, IL6, TNF
288.7IL1B, IL6, TNF
298.7IL1B, IL6, TNF
308.7IL1B, IL6, TNF
318.7IL1B, IL6, TNF
328.7IL1B, IL6, TNF
338.6IL1B, IL2, TNF
348.6IL1B, IL2, TNF
35
Show member pathways
8.2IL1B, IL2, IL6, TNF
36
Show member pathways
8.2IL1B, IL2, IL6, TNF
37
Show member pathways
8.2IL1B, IL2, IL6, TNF
388.2IL1B, IL2, IL6, TNF
39
Show member pathways
8.2IL1B, IL2, IL6, TNF
408.2IL1B, IL2, IL6, TNF
418.2IL1B, IL2, IL6, TNF
428.2IL1B, IL2, IL6, TNF
43
Show member pathways
8.2IL1B, IL2, IL6, TNF
44
Show member pathways
8.2IL1B, IL2, IL6, TNF
45
Show member pathways
8.2IL1B, IL2, IL6, TNF
46
Show member pathways
8.2IL1B, IL2, IL6, TNF
47
Show member pathways
8.2IL1B, IL2, IL6, TNF
48
Show member pathways
8.2IL1B, IL2, IL6, TNF
49
Show member pathways
7.7IL1B, IL2, IL6, NGF, TNF
50
Show member pathways
7.7IL1B, IL2, IL6, NGF, TNF

GO Terms for genes affiliated with Burning Mouth Syndrome

About this section

Cellular components related to Burning Mouth Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:000989710.0IL6, TNF, TRPV1
2extracellular regionGO:00055767.8IL1B, IL2, IL6, NGF, TAC1, TNF
3extracellular spaceGO:00056157.6IL1B, IL2, IL6, TAC1, TNF

Biological processes related to Burning Mouth Syndrome according to GeneCards Suite gene sharing:

(show all 43)
idNameGO IDScoreTop Affiliating Genes
1behavioral response to painGO:004826610.5SCN9A, TRPV1
2cellular response to cytokine stimulusGO:007134510.5IL6, TRPV1
3epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.3IL6, TNF
4negative regulation of lipid storageGO:001088810.3IL6, TNF
5cellular response to nerve growth factor stimulusGO:199009010.3TAC1, TRPV1
6positive regulation of chemokine productionGO:003272210.3IL6, TNF
7extrinsic apoptotic signaling pathway via death domain receptorsGO:000862510.3NGF, TNF
8positive regulation of immunoglobulin secretionGO:005102410.2IL2, IL6
9positive regulation of acute inflammatory responseGO:000267510.2IL6, TAC1
10fever generationGO:000166010.1IL1B, TRPV1
11response to painGO:004826510.0TAC1, TRPV1
12extrinsic apoptotic signaling pathway in absence of ligandGO:00971929.9IL1B, IL2
13lipopolysaccharide-mediated signaling pathwayGO:00316639.9IL1B, TNF
14negative regulation of extrinsic apoptotic signaling pathway in absence of ligandGO:20012409.9IL1B, TNF
15negative regulation of lipid catabolic processGO:00509959.9IL1B, TNF
16positive regulation of calcidiol 1-monooxygenase activityGO:00605599.9IL1B, TNF
17positive regulation of chemokine biosynthetic processGO:00450809.9IL1B, TNF
18positive regulation of fever generationGO:00316229.9IL1B, TNF
19positive regulation of heterotypic cell-cell adhesionGO:00341169.8IL1B, TNF
20positive regulation of interleukin-8 productionGO:00327579.8IL1B, TNF
21positive regulation of membrane protein ectodomain proteolysisGO:00510449.8IL1B, TNF
22positive regulation of NF-kappaB import into nucleusGO:00423469.8IL1B, TNF
23positive regulation of phagocytosisGO:00507669.8IL1B, TNF
24protein kinase B signalingGO:00434919.7IL1B, TNF
25regulation of establishment of endothelial barrierGO:19031409.7IL1B, TNF
26regulation of I-kappaB kinase/NF-kappaB signalingGO:00431229.7IL1B, TNF
27positive regulation of cytosolic calcium ion concentrationGO:00072049.7IL2, TAC1, TRPV1
28positive regulation of apoptotic processGO:00430659.5IL6, NGF, TNF, TRPV1
29positive regulation of interleukin-6 productionGO:00327559.4IL1B, IL6, TNF
30positive regulation of NF-kappaB transcription factor activityGO:00510929.4IL1B, IL6, TNF
31positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.4IL1B, IL6, TNF
32MAPK cascadeGO:00001659.3IL1B, IL2, TNF
33positive regulation of T cell proliferationGO:00421029.3IL1B, IL2, IL6
34positive regulation of interferon-gamma productionGO:00327299.3IL1B, IL2, TNF
35positive regulation of protein phosphorylationGO:00019349.3IL1B, IL2, TNF
36sensory perception of painGO:00192339.2SCN9A, TAC1, TRPV1
37sequestering of triglycerideGO:00307309.1IL1B, TNF
38response to lipopolysaccharideGO:00324969.1IL1B, IL6, TAC1
39positive regulation of nitric oxide biosynthetic processGO:00454299.1IL1B, IL6, TNF, TRPV1
40positive regulation of gene expressionGO:00106289.0IL1B, IL6, NGF, TNF
41immune responseGO:00069559.0IL1B, IL2, IL6, TNF
42cell-cell signalingGO:00072678.8IL1B, IL2, NGF, TAC1
43inflammatory responseGO:00069548.1IL1B, IL6, SCN9A, TAC1, TNF, TRPV1

Molecular functions related to Burning Mouth Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1growth factor activityGO:00080839.1IL2, IL6, NGF
2cytokine activityGO:00051258.8IL1B, IL2, IL6, TNF

Sources for Burning Mouth Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet